Effects of a Stretching Protocol in Patients With Hip Osteoarthritis

January 17, 2020 updated by: Luis Ceballos Laita, Universidad de Zaragoza

Effects of a Stretching Protocol of Hip Flexors in Patients With Mild to Moderate Hip Osteoarthritis

Hip osteoarthritis (OA) is one of the most prevalent chronic disease in the world. Clinical guidelines recommend non-pharmacological conservative treatments for the management of OA. Hip flexors seems to play an important role in the development of hip OA but there is no published studies evaluating the results of a stretching protocol of hip flexors in hip OA patients.

The objective of this trial is to evaluate if a stretching protocol of hip flexors is more effective in symptoms, functional capacity , range of motion, strength, muscular length, pain threshold and anxiety and depression compared to control.

For this purpose the investigators conduct a single-group, pretest-posttest clinical trial.The investigators included patients diagnosed of hip osteoarthritis Grade I-III by Scale of Kellgren and Lawrence.

The variables are measured at the beginning and at the end of treatment of the control phase, and at the end of the stretching protocol phase.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Soria, Spain, 42004
        • Sandra Jiménez del Barrio
      • Zaragoza, Spain, 50008
        • Luis Ceballos Laita

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diagnosed medically with a X-Ray test
  • American College of Rheumatology Criteria

Exclusion Criteria:

  • Secondary osteoarthritis by a traumatism, Paget disease, inflammatory or metabolic disease, congenital diseases etc.
  • Vascular or neurological disease.
  • Musculoskeletal pathologies in lumbar spine, pelvis or lower limbs
  • Grade IV in Kellgren and Laurence Scale

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Interventional group
Hip flexors stretching protocol
Stretching protocol of rectus femoris, vastus lateralis and iliopsoas according to Kaltenborn- Evjenth Orthopaedic Manual Therapy Concept (OMT)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes from baseline in pain intensity
Time Frame: 3 weeks
Visual Analogic Scale
3 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional Capacity
Time Frame: 3 weeks
The investigators measure the functional capacity with Timed Up and Go test (TUG)
3 weeks
WOMAC questionnaire
Time Frame: 3 weeks
WOMAC questionnaire
3 weeks
Hip Range of Motion
Time Frame: 3 weeks
Digital inclinometer according to Pua et al., 2008
3 weeks
Muscular strength
Time Frame: 3 weeks
The investigators measure the hip strength with a hand held dynamometer (Lafayette)
3 weeks
Muscular length
Time Frame: 3 weeks
The investigators measure the muscular length with an inclinometer
3 weeks
Pressure Pain threshold
Time Frame: 3 weeks
Pressure algometry measured by digital algometer
3 weeks
Anxiety and Depression
Time Frame: 3 weeks
Hospital Anxiety and Depression Scale (HADS)
3 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2018

Primary Completion (Actual)

November 30, 2018

Study Completion (Actual)

December 30, 2018

Study Registration Dates

First Submitted

August 17, 2018

First Submitted That Met QC Criteria

October 10, 2018

First Posted (Actual)

October 11, 2018

Study Record Updates

Last Update Posted (Actual)

January 21, 2020

Last Update Submitted That Met QC Criteria

January 17, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The patient data were confidential and were assigned a number to each patient to maintain confidentiality

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Osteoarthritis

Clinical Trials on Hip flexors stretching protocol

3
Subscribe